Literature DB >> 10525038

ABC1: connecting yellow tonsils, neuropathy, and very low HDL.

H H Hobbs1, D J Rader.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10525038      PMCID： PMC408871          DOI： 10.1172/JCI8509

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  18 in total

1.  The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease.

Authors:  M Bodzioch; E Orsó; J Klucken; T Langmann; A Böttcher; W Diederich; W Drobnik; S Barlage; C Büchler; M Porsch-Ozcürümez; W E Kaminski; H W Hahmann; K Oette; G Rothe; C Aslanidis; K J Lackner; G Schmitz
Journal:  Nat Genet       Date:  1999-08       Impact factor: 38.330

2.  Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency.

Authors:  A Brooks-Wilson; M Marcil; S M Clee; L H Zhang; K Roomp; M van Dam; L Yu; C Brewer; J A Collins; H O Molhuizen; O Loubser; B F Ouelette; K Fichter; K J Ashbourne-Excoffon; C W Sensen; S Scherer; S Mott; M Denis; D Martindale; J Frohlich; K Morgan; B Koop; S Pimstone; J J Kastelein; J Genest; M R Hayden
Journal:  Nat Genet       Date:  1999-08       Impact factor: 38.330

3.  Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages.

Authors:  T Langmann; J Klucken; M Reil; G Liebisch; M F Luciani; G Chimini; W E Kaminski; G Schmitz
Journal:  Biochem Biophys Res Commun       Date:  1999-04-02       Impact factor: 3.575

Review 4.  Biochemical, cellular, and pharmacological aspects of the multidrug transporter.

Authors:  S V Ambudkar; S Dey; C A Hrycyna; M Ramachandra; I Pastan; M M Gottesman
Journal:  Annu Rev Pharmacol Toxicol       Date:  1999       Impact factor: 13.820

Review 5.  Beyond LDL cholesterol reduction.

Authors:  H R Superko
Journal:  Circulation       Date:  1996-11-15       Impact factor: 29.690

6.  Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia.

Authors:  N J Stone; R I Levy; D S Fredrickson; J Verter
Journal:  Circulation       Date:  1974-03       Impact factor: 29.690

7.  Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1.

Authors:  S Rust; M Rosier; H Funke; J Real; Z Amoura; J C Piette; J F Deleuze; H B Brewer; N Duverger; P Denèfle; G Assmann
Journal:  Nat Genet       Date:  1999-08       Impact factor: 38.330

8.  The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway.

Authors:  R M Lawn; D P Wade; M R Garvin; X Wang; K Schwartz; J G Porter; J J Seilhamer; A M Vaughan; J F Oram
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

Review 9.  Homozygous Tangier disease and cardiovascular disease.

Authors:  C Serfaty-Lacrosniere; F Civeira; A Lanzberg; P Isaia; J Berg; E D Janus; M P Smith; P H Pritchard; J Frohlich; R S Lees
Journal:  Atherosclerosis       Date:  1994-05       Impact factor: 5.162

10.  Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease.

Authors:  G A Francis; R H Knopp; J F Oram
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808
View more
  21 in total

1.  PMP22 Regulates Cholesterol Trafficking and ABCA1-Mediated Cholesterol Efflux.

Authors:  Ye Zhou; Joshua R Miles; Hagai Tavori; Min Lin; Habibeh Khoshbouei; David R Borchelt; Hannah Bazick; Gary E Landreth; Sooyeon Lee; Sergio Fazio; Lucia Notterpek
Journal:  J Neurosci       Date:  2019-05-06       Impact factor: 6.167

2.  In vivo tissue cholesterol efflux is reduced in carriers of a mutation in APOA1.

Authors:  Adriaan G Holleboom; Lily Jakulj; Remco Franssen; Julie Decaris; Menno Vergeer; Joris Koetsveld; Jayraz Luchoomun; Alexander Glass; Marc K Hellerstein; John J P Kastelein; G Kees Hovingh; Jan Albert Kuivenhoven; Albert K Groen; Scott M Turner; Erik S G Stroes
Journal:  J Lipid Res       Date:  2013-05-06       Impact factor: 5.922

3.  Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux.

Authors:  Taro E Akiyama; Shuichi Sakai; Gilles Lambert; Christopher J Nicol; Kimihiko Matsusue; Satish Pimprale; Ying-Hue Lee; Mercedes Ricote; Christopher K Glass; H Bryan Brewer; Frank J Gonzalez
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

Review 4.  ATP-binding cassette transporter A1: from metabolism to neurodegeneration.

Authors:  Radosveta Koldamova; Nicholas F Fitz; Iliya Lefterov
Journal:  Neurobiol Dis       Date:  2014-05-17       Impact factor: 5.996

Review 5.  High-density lipoprotein and atherosclerosis: Roles of lipid transporters.

Authors:  Yoshinari Uehara; Keijiro Saku
Journal:  World J Cardiol       Date:  2014-10-26

6.  In vivo triglyceride synthesis in subcutaneous adipose tissue of humans correlates with plasma HDL parameters.

Authors:  Demidmaa Tuvdendorj; Alejandro O Munoz; Viviana Ruiz-Barros; Jean-Marc Schwarz; Giuseppe Montalto; Manisha Chandalia; Lawrence C Sowers; Manfredi Rizzo; Elizabeth J Murphy; Nicola Abate
Journal:  Atherosclerosis       Date:  2016-06-13       Impact factor: 5.162

7.  Chlordecone altered hepatic disposition of [14C]cholesterol and plasma cholesterol distribution but not SR-BI or ABCG8 proteins in livers of C57BL/6 mice.

Authors:  Junga Lee; Richard C Scheri; Lawrence R Curtis
Journal:  Toxicol Appl Pharmacol       Date:  2008-02-06       Impact factor: 4.219

8.  ABCA1 plays no role in the centripetal movement of cholesterol from peripheral tissues to the liver and intestine in the mouse.

Authors:  Chonglun Xie; Stephen D Turley; John M Dietschy
Journal:  J Lipid Res       Date:  2009-03-12       Impact factor: 5.922

Review 9.  Approach to the patient with extremely low HDL-cholesterol.

Authors:  Daniel J Rader; Emil M deGoma
Journal:  J Clin Endocrinol Metab       Date:  2012-10       Impact factor: 5.958

10.  Multiple splice defects in ABCA1 cause low HDL-C in a family with hypoalphalipoproteinemia and premature coronary disease.

Authors:  Jeffrey Rhyne; Myrna M Mantaring; David F Gardner; Michael Miller
Journal:  BMC Med Genet       Date:  2009-01-08       Impact factor: 2.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.